Clinical Trials Sponsored by Baker Heart and Diabetes Institute

Total 6624 results

Baker Heart and Diabetes Institute

Recruiting

Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)

Heart Failure

Australia
Baker Heart and Diabetes Institute

Recruiting

Early Detection of Coronary Artery Disease by Polygenic and Metabolic Risk Scoring (EDCAD-PMS)

Coronary Artery Disease

Australia
Baker Heart and Diabetes Institute

Withdrawn

Study of High Dosage of Losartan in Comparison to Low Dose of Losartan in Heart Failure Patients

Heart Failure
Baker Heart and Diabetes Institute

Not yet recruiting

Reducing Cognitive Impairment by Management of Heart Failure as a Modifiable Risk Factor (Cog-HF)

Heart Failure | Cognitive Impairment | Dementia | Cognitive Change | Cognitive Decline | Left Ventricular Dysfunction
Baker Heart and Diabetes Institute

Completed

Effect of Ghrelin on Sympathetic Nervous System

Healthy | Obesity

Australia
Baker Heart and Diabetes Institute

Terminated

Renal Denervation for Complicated Hypertension (RDNP-2012-03)

Hypertension

Australia
Baker Heart and Diabetes Institute

Terminated

The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication

Peripheral Arterial Disease | Intermittent Claudication

Australia
Baker Heart and Diabetes Institute

Recruiting

Risk-guided Disease Management Plan to Prevent Heart Failure in Patients Treated With Previous Chemotherapy (REDEEM)

Heart Failure

Australia
Baker Heart and Diabetes Institute

Completed

Sympathetic Nervous System Inhibition for the Treatment of Diabetic Kidney Disease

Diabetic Nephropathies

Australia
Baker Heart and Diabetes Institute

Completed

Renal Denervation to Improve Outcomes in Patients With End-stage Renal Disease

Hypertension | End-stage Renal Disease

Australia
Baker Heart and Diabetes Institute

Completed

Sham Controlled Clinical Trial of Renal Denervation in Patients With Resistant Hypertension

Hypertension

Australia
Baker Heart and Diabetes Institute

Withdrawn

Renal Denervation for Uncontrolled Hypertension (RDNP-2012-02)

Hypertension
Baker Heart and Diabetes Institute

Terminated

Renal Denervation for Resistant Hypertension (RDNP-2012-01)

Hypertension

Australia
Baker Heart and Diabetes Institute

Completed

Polycystic Ovary Syndrome - Improving Outcomes

Polycystic Ovary Syndrome

Australia
Baker Heart and Diabetes Institute

Unknown

Study of the Effect of Moxonidine and Diet on Sympathetic Functions in Young Adults With Obesity

Obesity | Overweight

Australia
Baker Heart and Diabetes Institute

Unknown

The Effect of Moxonidine on Blood Pressure and Regression of Early Target Organ Damage in Young Subjects With Abdominal Obesity and Hypertension

Hypertension | Abdominal Obesity

Australia
Bayside Health
Baker Heart and Diabetes Institute

Terminated

Effects of Heart Rate Reduction on Central Arterial Pressure in Healthy Individuals

Central Arterial Pressure

Australia
Bayside Health
Baker Heart and Diabetes Institute

Unknown

Eplerenone in the Management of Abdominal Aortic Aneurysms

Aortic Aneurysm, Abdominal

Australia
Novartis Pharmaceuticals
Baker Heart and Diabetes Institute

Completed

Valsartan Intensified Primary Care Reduction of Blood Pressure Study (VIPER-BP)

Hypertension

United States, Australia
Bayside Health
The Alfred; Baker Heart and Diabetes Institute

Unknown

Enhancement of Brown Adipose Tissue Function Via Chronic Pharmacological Treatment

Obesity | Cardiovascular Disease | Type 2 Diabetes

Australia
Resverlogix Corp
Nucleus Network Ltd; Baker Heart and Diabetes Institute

Completed

The Effects of RVX000222 on Glucose Metabolism in Individuals With Pre-diabetes

Diabetes

Australia
Karolinska Institutet
Region Stockholm; Australian Catholic University; Baker Heart and Diabetes Institute

Completed

Frequent Activity Snacks Breaks (FABS)

Obesity | Sedentary Lifestyle | Insulin Resistance

Sweden
Bayside Health
Baker Heart Research Institute; International Diabetes Institute, Australia

Terminated

Type 2 Diabetes and Exercise - A Pilot Study

Type 2 Diabetes

Australia
Baker Heart Research Institute

Unknown

Cortisol and Nutritional Sympathetic Responsiveness

Obesity | Metabolic Syndrome | Insulin Resistance

Australia
Baker Heart Research Institute

Unknown

The Effects of Weight Loss on Neuroadrenergic Function

Obesity | Metabolic Syndrome | Type 2 Diabetes

Australia
Baker Heart Research Institute

Completed

The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
ResMed
Royal North Shore Hospital; International Diabetes Center at Park Nicollet; Baker...

Completed

GLYCOSA Study:Effect of PAP Treatment on Glycemic Control in Patients With Type 2 Diabetes

Diabetes Mellitus Type 2

United States, Australia, Canada
Baker Heart and Diabetes Institute
The Alfred; Monash Medical Centre; Ballarat Health Services

Completed

Major Depressive Disorder - Understanding The Link Between The Brain And The Heart (MDD)

Major Depressive Disorder

Australia
Baker Heart and Diabetes Institute
The Alfred; Monash Medical Centre; Ballarat Health Services

Withdrawn

Alleviating the Metabolic Side Effects of Antipsychotic Medications

Schizophrenia

Australia
University of Leicester
University Hospitals, Leicester; Loughborough University; Baker Heart and Diabetes...

Completed

The Effects of Reducing Prolonged Sitting Bouts in Individuals at High Risk of or With Type 2 Diabetes (UP FOR 5)

Type 2 Diabetes Mellitus

United Kingdom
Bayside Health
Monash University; Baker Heart and Diabetes Institute; Ambulance Victoria; FALCK...

Unknown

Air Verses Oxygen In myocarDial Infarction Study (AVOID)

Coronary Artery Disease | Acute Myocardial Infarction

Australia
Baker Heart and Diabetes Institute
Queen's University, Belfast; University of Melbourne; Heartwest; Western Health

Recruiting

Risk-guided Disease Management in Coronary Artery Disease (Risk-CAD)

Coronary Artery Disease | Chronic Disease | Nurse's Role

Australia
Baker Heart Research Institute
National Heart Foundation, Australia

Unknown

Effects of Pioglitazone Treatment on Sympathetic Nervous System Function in Metabolic Syndrome Obesity

Metabolic Syndrome

Australia
Baker Heart and Diabetes Institute
The Alfred; Monash Medical Centre; Servier Laboratories (Australia) Pty Ltd

Unknown

Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)

Australia
Bayside Health
Baker Heart Research Institute

Completed

Improving Metabolism With HDL Cholesterol

Diabetes | Heart Disease

Australia
Baker Heart Research Institute
National Health and Medical Research Council, Australia; Hoffmann-La Roche; Diabetes...

Completed

Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes

Diabetes Mellitus, Type 2

Australia
Universitaire Ziekenhuizen KU Leuven
Jessa Hospital; University Hospital, Antwerp; Baker Heart and Diabetes Institute and other collaborators

Recruiting

Prospective Athlete's Heart Study (Pro@Heart)

Athlete Heart

Australia, Belgium
Heart and Diabetes Center North-Rhine Westfalia

Completed

Beat-to-beat Variability in Persistent Atrial Fibrillation (BVAR-Afib)

Persistent Atrial Fibrillation

Germany
Heart and Diabetes Center North-Rhine Westfalia

Completed

Evaluation of Baroreflex Activation Therapy in Patients With Advanced Heart Failure

Heart Failure

Germany
Heart and Diabetes Center North-Rhine Westfalia

Completed

VItamin D Metabolism in SEnescent Cardiac Surgery Patients (VISE)

Coronary Artery Bypass Grafting | Heart Valve Surgery

Germany
Heart and Diabetes Center North-Rhine Westfalia

Recruiting

Correlation of FFR and iFR With Cardiac PET Perfusion in Patients With Severe Aortic Valve Stenosis (TAVI PET)

Coronary Artery Disease | Aortic Valve Stenosis

Germany
Heart and Diabetes Center North-Rhine Westfalia

Completed

Influence of Individualized Training on Cardiopulmonary Exercise Capacity in LVAD Patients

Heart Failure

Germany
Heart and Diabetes Center North-Rhine Westfalia

Completed

Quartet™ Bad Oeynhausen Trial (QUOTA)

Congestive Heart Failure | Cardiac Resynchronization Therapy

Germany
Heart and Diabetes Center North-Rhine Westfalia

Completed

Macronutrient Relations and Weight Loss in Obese Subjects

Obesity

Germany
Heart and Diabetes Center North-Rhine Westfalia

Completed

Noninvasive Pulse Contour Analysis for Hemodynamic Assessment in Patients With Chronic Heart Failure

Heart Failure

Germany
Heart and Diabetes Center North-Rhine Westfalia

Completed

Vitamin D and Outcome in Cardiac Surgery (Calcitop)

Cardiovascular Disease

Germany
Heart and Diabetes Center North-Rhine Westfalia

Completed

Vitamin D and Mortality in Heart Failure (EVITA)

Congestive Heart Failure

Germany
Heart and Diabetes Center North-Rhine Westfalia

Recruiting

Atrial Fibrillation and Diabetes Mellitus

Pathologic Processes | Heart Diseases | Cardiovascular Diseases | Atrial Fibrillation | Arrhythmias, Cardiac

Germany
Heart and Diabetes Center North-Rhine Westfalia

Recruiting

Transcatheter Tricuspid Valve Interventions and Right Ventricular Function: Evaluation With Magnetic Resonance Imaging

Tricuspid Valve Insufficiency

Germany
Heart and Diabetes Center North-Rhine Westfalia

Active, not recruiting

Tricuspid Cardiopulmonary Exercise Study (TRCPET)

Tricuspid Regurgitation

Germany

Clinical Trials Sponsored by Baker Heart and Diabetes Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations